Pro Medicus Limited (ASX:PME) is a Melbourne-based software owner and developer, licensing products to large US hospitals and Australian radiology clinics. The company has offices in Richmond, Victoria, Berlin, Germany and in the United States.
The Pro Medicus Ltd (ASX:PME) share price is down more than 5% in reaction to the company’s FY20 result.
Pro Medicus (ASX:PME) has won another sizeable contract in the US. Is it time to buy shares?
Melbourne-based Pro Medicus Ltd (ASX:PME) shares were trading 5% higher on Thursday following the release of its financial report.
The Pro Medicus (ASX:PME) share price is up after announcing a new US deal with Nines.
Pro Medicus (ASX:PME) made an announcement this morning about it showcasing its Visage AI Accelerator.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.13% at lunch.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.42% at lunch.
The Pro Medicus (ASX:PME) share price is rising after winning a new US-based long term contract.
The ASX 200 (INDEXASX:XJO)(^AXJO) is expected to open higher today, the USA’s S&P 500 Index (.INX) went up 0.97% on Friday.
